Enhancing Domestic Drug Manufacturing Competitiveness Act

I

119TH CONGRESS

1ST SESSION

H. R. 1405

To direct the Comptroller General of the United States to conduct a study

to assess the key regulatory barriers that impede the expansion or siting

of new pharmaceutical manufacturing facilities in the United States,

and for other purposes.